Navigation Links
Heart stem cell scientist to honor pioneering woman scientist in keynote speech
Date:4/9/2008

Professor Christine Mummery, one of the worlds leading heart stem cell experts, will later today (9 April) honour the memory of Dame Anne McLaren in the keynote lecture of the inaugural UK National Stem Cell Network Science Meeting in Edinburgh. Dr McLaren was an early pioneer of the study of embryonic germ cells and her research directly contributed to the development of IVF treatments and stem cell techniques.

Prof Mummery from the Netherlands is a leading expert in the study of cardiomyocytes the beating cells of the heart most particularly those derived from stem cells. She will inform the delegates at the UKNSCN conference that Dr McLaren was a leading figure in guiding the stem cell research community in learning the language and ethics of working with early human embryos in research. She will say that the UK regulations, which have allowed the country to take a strong lead in stem cell research, are in part due to Dr McLarens thoughtful input to the various committees that first examined the laws needed to govern IVF treatment.

Speaking ahead of her lecture, Prof Mummery said: Anne McLaren was one of the most thoughtful and sensitive stem cell scientists the scientific community has seen. Her views not only influenced the direction of UK regulation of the field which has helped thousands of couples through IVF treatment but also scientists considering ethical and regulatory questions across Europe.

Anne was also an excellent communicator of her research and, as well as commemorating her work, my lecture will highlight some of the cutting edge advances in todays stem cell research field.

Prof Mummerys lab in The Netherlands is a world leader in the study of the basic development of the heart and how embryonic stem cells differentiate into the cardiac and vascular cells that make up the adult heart.

Prof Mummery said: Stem cell therapies have the potential to help us to treat and manage a wide range of diseas
'/>"/>

Contact: Matt Goode
ukpo@uknscn.org
01-793-413-355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Drug for cluster headaches may cause heart problems
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. Restricting Blood Flow May Help Heart Bypass Patients
4. Urban Smog Tough on Young Adults Hearts
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. Vitamin Es lack of heart benefit linked to dosage
7. Drug That Lowers Resting Heart Rate Being Tested
8. Heart Attack Boosts Diabetes Risk
9. Embryonic Stem Cells Repair Human Heart
10. U of M study: Early treatment can reverse heart damage
11. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study by researchers from the Medical College of ... utilization for pain and other sickle cell disease complications ... of both providers and patients were also identified. ... assistant professor of pediatrics at the Medical College and ... will be presented at the American Society of Hematology ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... According to a recent study conducted by researchers at ... lead to a rise of certain// chemicals in the ... brain and nerve cell damage. This increase of chemicals ... and symptoms of lasting neurological damage. ,This ...
... published in PLoS Medicine online says that the life expectancy ... an Asian-American woman may live// two decades longer than an ... evidence is really quite clear that most of the gap ... young and middle-aged adult men and women and most of ...
... Sreemathy today visited the community health centre at Vizhinjam and ... of viral fever//. ,"In Tamil Nadu, the number ... managed to prevent the fever spreading further along the coast," ... day in August, but on Saturday the number was just ...
... the safest pain medication? Many people with osteoarthritis ... the painkillers called COX-2 inhibitors// to increased heart ... from a COX-2 drug to other medications, including ... and naproxen. But although NSAIDs are effective at ...
... the positive influence of having a baby and its benefits ... this research seem to suggest that women who are childless ... lives and may even face early death. ,According ... age are 20% more likely to die than their contemporaries, ...
... saw the conclusion of the first of a wave of ... as Wyeth defended// its hormone replacement therapy Prempro against claims ... ,Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the ... was negligent in not testing the drug and not knowing ...
Other Medicine News:Health News:Punch-Drunk Effect- Every blow matters 2
(Date:12/4/2009)... SAN DIEGO, Calif., Dec. 4 Suneva Medical, a ... of Philip Ranker as Vice President and Chief Financial ... all Suneva Medical,s general and administrative functions including finance, ... will also serve on the Company,s senior management team. ...
(Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
(Date:12/4/2009)... 4 Bayer Diabetes Care today announced the three grand ... Nick Jonas, of the Jonas Brothers, selected the winning video ... The grand prize is an in-person meeting today with Nick. ... like Nick, are: Caleb, age 6, from Danbury, CT, who ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Without Job Stress Retirees Sleep Better 60756 1Without Job Stress Retirees Sleep Better 60756 2PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 1PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 2PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 3PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 4PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 5Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 1Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 2Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 3Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 4
... And Japanese Study Suggests the Drug Improves Memory, ... Institute announced today that it has received positive,preliminary ... testing a,promising new drug application for the treatment ... announced in,September, is the first human clinical study ...
... /PRNewswire/ -- DiObex,Inc., a privately- held biopharmaceutical ... treat metabolic diseases, today,announced positive phase 2a ... Inhibitor. , In a recently completed multi-center, ... were,treated for two weeks to evaluate the ...
Other Medicine Technology:Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: